METHOD FOR PREDICTING THE RISK OF EXACERBATION OF CHRONIC GINGIVITIS IN PATIENTS WITH A NEW CORONAVIRUS INFECTION Russian patent published in 2022 - IPC G01N33/569 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to dentistry and microbiology, and can be used to predict the risk of exacerbation of chronic gingivitis in patients who have had a new coronavirus infection. The presence of microorganism species isolated from the gingival groove is assessed: Streptococcus oralis, Neisseria elongata, Streptococcus intermedius, Staphylococcus epidermidis, Corynebacterium durum, Neisseria subflava, Neisseria flavescens, Streptococcus sanguinis, Streptococcus mitis, Streptococcus gordonii, Veillonella parvula - group 1 and Haemophilus parainfluenza 2 Group. Based on the data obtained, 1 point is assigned in case of isolation of each microorganism from group 1 or the absence of a microorganism from group 2. Then the scores are summed up and get an index for predicting the risk of developing an exacerbation of chronic gingivitis. With an index value of more than 3, a high risk of developing an exacerbation of chronic gingivitis in patients who have had a new coronavirus infection is predicted. If the index value is less than or equal to 3, there is no risk of exacerbation of chronic gingivitis in patients who have had a new coronavirus infection.

EFFECT: method makes it possible to increase the accuracy of predicting the risk of exacerbation of chronic gingivitis in patients who have undergone a new coronavirus infection, due to the microbiological assessment of the species diversity of microflora isolated from the gingival groove.

1 cl, 2 dwg, 2 ex